The Use of Real World Evidence to Accelerate MedTech HTA Approval

Our panellists are:
Michael Branagan-Harris - CEO, Device Access UK
Mattias Kyhlstedt - CEO, Synergus
Professor Tom Clutton-Brock FRCP, FRCA, FFICM- Director, Medical Devices Testing and Evaluation Centre & Chair, NICE Interventional Procedures Advisory Committee
Dr Peter Walton - Managing Director, Dendrite Clinical Systems